
|Articles|April 1, 2004
Oral Rx for stress incontinence closer to approval
Sydney, Australia--Duloxetine, a selective serotonin and norepinephrinereuptake inhibitor, yields significant improvements in incontinent episodesand quality of life among women with stress urinary incontinence, and ispoised to become the first effective oral agent for the condition, an Australianurologist says.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Suzanne Merrill, MD, on recent progress with immunotherapy in bladder cancer
2
LUGPA 2025: Staying the course for independent urology practices
3
Scott Sellinger, MD, FACS, highlights 2025 LUGPA Annual Meeting
4
How the SURE procedure boosts efficiency in treating stones
5



















